Successful treatment of

Spela Stunf Pukl, Azra Herceg, Mojca Globočnik Petrovič, Vladimir Pfeifer

Open access · goldAbstract readCase Reports

In one paragraph

Article in American journal of ophthalmology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.2field-weighted citation impact, top 56% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Spela Stunf PuklFaculty of Medicine, University of Ljubljana, Vrazov trg 4, Ljubljana, Slovenia.

Azra HercegEye Hospital, University Clinical Center Ljubljana, Grablovičeva 46, 1000, Ljubljana, Slovenia.

Mojca Globočnik PetrovičEye Hospital, University Clinical Center Ljubljana, Grablovičeva 46, 1000, Ljubljana, Slovenia.

Vladimir PfeiferEye Hospital, University Clinical Center Ljubljana, Grablovičeva 46, 1000, Ljubljana, Slovenia.

Ljubljana University Medical Centre · SIUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To report the successful management of an anterior chamber (AC) infection after penetrating keratoplasty (PK) caused by Observation: A 53-year-old female had a PK in her right eye. The donor rim tested positive for Conclusions and Importance: Fungal intraocular infections after PK are usually devastating. Due to low intraocular penetration of topical antifungals, serial intracameral injections were used to maintain a therapeutic concentration of amphotericin B within the anterior chamber, and intravenous fluconazole was administered to protect against the spread of infection into the vitreous. A clinical response developed after two weeks. The reported case represents a favorable outcome using a multimodal approach.

Indexed as

Antifungal therapyDonor rim culturesFungal infectionIntracameral amphotericinPenetrating keratoplasty

Identifiers

PMID35265779

DOI10.1016/j.ajoc.2022.101466

PMCPMC8899226

OpenAlexW4214911695

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.